These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31125141)

  • 1. Exploring the effect of inhibitor AKB-9778 on VE-PTP by molecular docking and molecular dynamics simulation.
    Liu WS; Wang RR; Sun YZ; Li WY; Li HL; Liu CL; Ma Y; Wang RL
    J Cell Biochem; 2019 Oct; 120(10):17015-17029. PubMed ID: 31125141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes.
    Siragusa M; Oliveira Justo AF; Malacarne PF; Strano A; Buch A; Withers B; Peters KG; Fleming I
    Cardiovasc Res; 2021 May; 117(6):1546-1556. PubMed ID: 32653904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) Administration.
    Li G; Sachdev U; Peters K; Liang X; Lotze MT
    J Immunother; 2019 Sep; 42(7):237-243. PubMed ID: 31348125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2.
    Campochiaro PA; Sophie R; Tolentino M; Miller DM; Browning D; Boyer DS; Heier JS; Gambino L; Withers B; Brigell M; Peters K
    Ophthalmology; 2015 Mar; 122(3):545-54. PubMed ID: 25439435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.
    Shen J; Frye M; Lee BL; Reinardy JL; McClung JM; Ding K; Kojima M; Xia H; Seidel C; Lima e Silva R; Dong A; Hackett SF; Wang J; Howard BW; Vestweber D; Kontos CD; Peters KG; Campochiaro PA
    J Clin Invest; 2014 Oct; 124(10):4564-76. PubMed ID: 25180601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
    Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
    Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure.
    Li G; Nottebaum AF; Brigell M; Navarro ID; Ipe U; Mishra S; Gomez-Caraballo M; Schmitt H; Soldo B; Pakola S; Withers B; Peters KG; Vestweber D; Stamer WD
    Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):12. PubMed ID: 33315051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin.
    Frye M; Dierkes M; Küppers V; Vockel M; Tomm J; Zeuschner D; Rossaint J; Zarbock A; Koh GY; Peters K; Nottebaum AF; Vestweber D
    J Exp Med; 2015 Dec; 212(13):2267-87. PubMed ID: 26642851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2.
    Drexler HCA; Vockel M; Polaschegg C; Frye M; Peters K; Vestweber D
    Mol Cell Proteomics; 2019 Oct; 18(10):2058-2077. PubMed ID: 31427368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
    Campochiaro PA; Peters KG
    Curr Diab Rep; 2016 Dec; 16(12):126. PubMed ID: 27778249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics simulation of the interaction between protein tyrosine phosphatase 1B and aryl diketoacid derivatives.
    Wang Q; Gao J; Liu Y; Liu C
    J Mol Graph Model; 2012 Sep; 38():186-93. PubMed ID: 23085163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of triaryl-based sulfamic acid derivatives as HPTPβ inhibitors.
    Zhang W; Wei Z; Huang G; Xie F; Zheng Z; Li S
    Bioorg Med Chem; 2020 Dec; 28(23):115777. PubMed ID: 32992253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression.
    Campochiaro PA; Khanani A; Singer M; Patel S; Boyer D; Dugel P; Kherani S; Withers B; Gambino L; Peters K; Brigell M;
    Ophthalmology; 2016 Aug; 123(8):1722-1730. PubMed ID: 27236272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the effect of aplidin on low molecular weight protein tyrosine phosphatase by molecular docking and molecular dynamic simulation study.
    Sun YZ; Wu JW; Lu XH; Ma Y; Wang RL
    Comput Biol Chem; 2019 Dec; 83():107123. PubMed ID: 31561070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression.
    Goel S; Gupta N; Walcott BP; Snuderl M; Kesler CT; Kirkpatrick ND; Heishi T; Huang Y; Martin JD; Ager E; Samuel R; Wang S; Yazbek J; Vakoc BJ; Peterson RT; Padera TP; Duda DG; Fukumura D; Jain RK
    J Natl Cancer Inst; 2013 Aug; 105(16):1188-201. PubMed ID: 23899555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors.
    Murthy VS; Kulkarni VM
    Bioorg Med Chem; 2002 Apr; 10(4):897-906. PubMed ID: 11836096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational screening of fatty acid synthase inhibitors against thioesterase domain.
    Panman W; Nutho B; Chamni S; Dokmaisrijan S; Kungwan N; Rungrotmongkol T
    J Biomol Struct Dyn; 2018 Nov; 36(15):4114-4125. PubMed ID: 29161996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins.
    Mori M; Murata Y; Kotani T; Kusakari S; Ohnishi H; Saito Y; Okazawa H; Ishizuka T; Mori M; Matozaki T
    J Cell Physiol; 2010 Jul; 224(1):195-204. PubMed ID: 20301196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of the apo form and a complex of human LMW-PTP with a phosphonic acid provide new evidence of a secondary site potentially related to the anchorage of natural substrates.
    Fonseca EMB; Trivella DBB; Scorsato V; Dias MP; Bazzo NL; Mandapati KR; de Oliveira FL; Ferreira-Halder CV; Pilli RA; Miranda PCML; Aparicio R
    Bioorg Med Chem; 2015 Aug; 23(15):4462-4471. PubMed ID: 26117648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the binding mechanism of mercaptoguanine derivatives as inhibitors of HPPK by docking and molecular dynamics simulations.
    Marimuthu P; Singaravelu K; Namasivayam V
    J Biomol Struct Dyn; 2017 Dec; 35(16):3507-3521. PubMed ID: 27844507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.